Epilepsy genetics revolutionizes clinical practice

Neuropediatrics

Volumn 45, Issue 2, 2014, Pages 70-74

  Scheffer, Ingrid E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

DEPDC5; epilepsy; epilepsy syndromes; epileptic encephalopathies; genetics

Indexed keywords

DEPDC5 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; BRAIN DISEASE; CLINICAL PRACTICE; CORTICAL DYSPLASIA; DISEASE PREDISPOSITION; EPILEPSY; EXOME; FAMILY STUDY; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; MOLECULAR GENETICS; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENICITY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUBEROUS SCLEROSIS; GENETICS;

EPILEPSY; GENETIC RESEARCH; HUMANS;

EID: 84897110754     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0034-1371508     Document Type: Review

References (31)

1. Chen Y., Lu J., Pan H., et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol: 2003; 54 2 239 243 (Pubitemid 36909623)
2. Heron S. E., Phillips H. A., Mulley J. C., et al. Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann Neurol: 2004; 55 4 595 596 (Pubitemid 38391980)
3. Helbig I., Mefford H. C., Sharp A. J., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet: 2009; 41 2 160 162
4. de Kovel C. G., Trucks H., Helbig I., et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain: 2010; 133 Pt 1 23 32
5. Dibbens L. M., Mullen S., Helbig I., et al. EPICURE Consortium. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet: 2009; 18 19 3626 3631
6. Scheffer I. E., Grinton B. E., Heron S. E., et al. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology: 2012; 79 21 2104 2108
7. Arsov T., Mullen S. A., Rogers S., et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol: 2012; 72 5 807 815
8. De Vivo D. C., Trifiletti R. R., Jacobson R. I., Ronen G. M., Behmand R. A., Harik S. I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med: 1991; 325 10 703 709
9. Steinlein O. K., Mulley J. C., Propping P., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet: 1995; 11 2 201 203
10. +-channel beta1 subunit gene SCN1B. Nat Genet: 1998; 19 4 366 370 (Pubitemid 28357909)
11. Hildebrand M. S., Dahl H. HM, Damiano J. A., Smith R. JH, Scheffer I. E., Berkovic S. F. Recent advances in the molecular genetics of epilepsy. J Med Genet: 2013; 50 5 271 279
12. Scheffer I. E., Bhatia K. P., Lopes-Cendes I., et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet: 1994; 343 8896 515 517 (Pubitemid 24062287)
13. De Fusco M., Becchetti A., Patrignani A., et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet: 2000; 26 3 275 276
14. Aridon P., Marini C., Di Resta C., et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet: 2006; 79 2 342 350 (Pubitemid 44141832)
15. Scheffer I. E., Bhatia K. P., Lopes-Cendes I., et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain: 1995; 118 Pt 1 61 73
16. Derry C. P., Heron S. E., Phillips F., et al. Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability. Epilepsia: 2008; 49 12 2125 2129
17. Heron S. E., Smith K. R., Bahlo M., et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet: 2012; 44 11 1188 1190
18. Scheffer I. E., Phillips H. A., O'Brien C. E., et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol: 1998; 44 6 890 899 (Pubitemid 28558250)
19. Xiong L., Labuda M., Li D. S., et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet: 1999; 65 6 1698 1710 (Pubitemid 30468683)
20. Klein K. M., O'Brien T. J., Praveen K., et al. Familial focal epilepsy with variable foci mapped to chromosome 22q12: expansion of the phenotypic spectrum. Epilepsia: 2012; 53 8 e151 e155
21. Dibbens L. M., de Vries B., Donatello S., et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet: 2013; 45 5 546 551
22. Callenbach P. MC, van den Maagdenberg A. MJM, Hottenga J. J., et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia: 2003; 44 10 1298 1305 (Pubitemid 37280374)
23. Berkovic S. F., Serratosa J. M., Phillips H. A., et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia: 2004; 45 9 1054 1060 (Pubitemid 39238115)
24. Morales-Corraliza J., Gómez-Garre P., Sanz R., Díaz-Otero F., Gutiérrez-Delicado E., Serratosa J. M. Familial partial epilepsy with variable foci: a new family with suggestion of linkage to chromosome 22q12. Epilepsia: 2010; 51 9 1910 1914
25. Shaw R. J. Cell biology. GATORs take a bite out of mTOR. Science: 2013; 340 6136 1056 1057
26. Bar-Peled L., Chantranupong L., Cherniack A. D., et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science: 2013; 340 6136 1100 1106
27. Carvill G. L., Heavin S. B., Yendle S. C., et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet: 2013; 45 7 825 830
28. Carvill G. L., Regan B. M., Yendle S. C., et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet: 2013; 45 9 1073 1076
29. Allen A. S., Berkovic S. F., Cossette P., et al. Epi4K Consortium; Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature: 2013; 501 (7466): 217 221
30. Depienne C., Trouillard O., Gourfinkel-An I., et al. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet: 2010; 47 6 404 410
31. Dibbens L. M., Tarpey P. S., Hynes K., et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet: 2008; 40 6 776 781 (Pubitemid 351748867)